{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:01:02Z","timestamp":1781665262058,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ophtha.2018.09.046","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T12:45:11Z","timestamp":1548161111000},"page":"192-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dry Eye Research\u2014Still Regressing?"],"prefix":"10.1016","volume":"126","author":[{"given":"Gerami D.","family":"Seitzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2018.09.046_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 Fatty acid supplementation for the treatment of dry eye disease","volume":"378","author":"Asbell","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2018.09.046_bib2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hr\u00f3bjartsson","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ophtha.2018.09.046_bib3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II Report Executive Summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2018.09.046_bib4","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2147\/OPTH.S89700","article-title":"Associations between signs and symptoms of dry eye disease: a systematic review","volume":"9","author":"Bartlett","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2018.09.046_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ophtha.2017.05.024","article-title":"Brand medications and Medicare part D: how eye care providers\u2019 prescribing patterns influence costs","volume":"125","author":"Newman-Casey","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.09.046_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamainternmed.2017.7904","article-title":"A\u00a0clear-eyed view of Restasis and chronic dry eye disease","volume":"178","author":"Schwartz","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ophtha.2018.09.046_bib7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMra1407936","article-title":"Dry eye","volume":"378","author":"Clayton","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2018.09.046_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","article-title":"Lifitegrast for the treatment of dry eye disease: results of a phase iii, randomized, double-masked, placebo-controlled trial (OPUS-3)","volume":"124","author":"Holland","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.09.046_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2018.09.046_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-15-68","article-title":"The clinical course of low back pain: a meta- analysis comparing outcomes in randomised clinical trials (RCTs) and observational studies","volume":"15","author":"Artus","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ophtha.2018.09.046_bib11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.1067176","article-title":"Placebo and opioid analgesia: imaging a shared neuronal network","volume":"295","author":"Petrovic","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ophtha.2018.09.046_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3959(01)00296-2","article-title":"Response expectancies in placebo analgesia and their clinical relevance","volume":"93","author":"Pollo","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ophtha.2018.09.046_bib13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/ICO.0000000000001216","article-title":"Patients\u2019 perceived treatment effectiveness in dry eye disease","volume":"36","author":"Kheirkhah","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2018.09.046_bib14","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200105243442106","article-title":"Is the placebo powerless?: an analysis of clinical trials comparing placebo with no treatment","volume":"344","author":"Hr\u00f3bjartsson","year":"2001","journal-title":"N\u00a0Engl J Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018320724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018320724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T12:45:14Z","timestamp":1548161114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642018320724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0161642018320724"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.09.046","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dry Eye Research\u2014Still Regressing?","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.09.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}